(Q34500791)

2 August 2017

1 reference

title

Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients (English)

1 reference

2 August 2017

0 references

Graeff FG

1

1 reference

2 August 2017

Silva M

2

1 reference

2 August 2017

Del Ben CM

3

1 reference

2 August 2017

Zuardi AW

4

1 reference

2 August 2017

Hetem LA

5

1 reference

2 August 2017

Guimarães FS

6

1 reference

2 August 2017

language of work or name

1 reference

1 December 2001

1 reference

Neuroscience & Biobehavioral Reviews

2 August 2017

1 reference

2 August 2017

25

1 reference

2 August 2017

7-8

1 reference

2 August 2017

753-759

1 reference

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Social phobia in the general population: prevalence and sociodemographic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Dual role of 5-HT in defense and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Role of the amygdala and periaqueductal gray in anxiety and panic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Effect of metergoline on human anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Ritanserin facilitates anxiety in a simulated public-speaking paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Effect of chlorimipramine and maprotiline on experimental anxiety in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Effects of ritanserin on aversive classical conditioning in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Addition of d-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Panic disorder. Pathophysiology and drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Simulated public speaking as a model of clinical anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

The action of sedatives on brain stem oculomotor systems in man

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Normative data for the personal report of confidence as a speaker

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Anti-aversive role of serotonin in the dorsal periaqueductal grey matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Opposite effects of nefazodone in two human models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Controlling panic attacks with fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Fenfluramine provocation of anxiety in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Vulnerability and conditioning in relation to the human menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

Changes in psychophysiological and conditioning variables during chlormethiazole-medicated and unmedicated ethanol withdrawal: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900055-0

7 January 2021

10.1016/S0149-7634(01)00055-0

Identifiers

DOI

1 reference

2 August 2017

1 reference